Mathew A. Vadas

20.7k citations

207 papers · 17.4k indexed · 3 hit papers · h-index 69

Impact in

Immunology and Allergy top 0.1%
- Cell Adhesion Molecules Research
Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in

Immunology and Allergy 46
- Cell Adhesion Molecules Research 45
Immunology 83
- Immune Response and Inflammation 33
- Immune Cell Function and Interaction 22

Co-authors: Jennifer R. Gamble Yeesim Khew‐Goodall Gregory J. Goodall Andrew G. Bert Simon C. Barry Pu Xia Anna Tsykin Philip A. Gregory
Journals: The Journal of Immunology (17 papers)Journal of Biological Chemistry (15 papers)Proceedings of the National Academy of Sciences (13 papers)The Journal of Experimental Medicine (8 papers)Blood (7 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mathew A. Vadas

207 papers receiving 16.7k citations

Hit Papers

align trajectories log scale

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 2008 · 3.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Nature Cell Biology
1995 Arteriosclerosis Thrombosis and Vascular Biology
1979 The Journal of Immunology

Peers

Countries citing papers authored by Mathew A. Vadas

Since Specialization

Citations

This map shows the geographic impact of Mathew A. Vadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew A. Vadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew A. Vadas more than expected).

Fields of papers citing papers by Mathew A. Vadas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew A. Vadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew A. Vadas. The network helps show where Mathew A. Vadas may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathew A. Vadas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathew A. Vadas Line = papers co-authored together Mathew A. Vadas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Endothelial cell senescence — understanding aging and disease Current Opinion in Physiology ·Paul Coleman, Ka Ka Ting, Yanfei Qi, Mathew A. Vadas, Jennifer R. Gamble	2023	1
2	Vascular senescence and leak are features of the early breakdown of the blood–brain barrier in Alzheimer’s disease models GeroScience ·Ka Ka Ting, Paul Coleman, Hani Jieun Kim, Yang Zhao, L.C. Groen, Ngan Ching Cheng, Wan Li, Dilini Gunatilake, Daniel M. Johnstone, Lipin Loo, G. Gregory Neely, Pengyi Yang, Jürgen Götz, Mathew A. Vadas, Jennifer R. Gamble	2023	42
3	The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking Cancers ·Yang Zhao, Ka Ka Ting, Paul Coleman, Yanfei Qi, Jinbiao Chen, Mathew A. Vadas, Jennifer R. Gamble	2021	16
4	The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours Cancer Letters ·Yang Zhao, Jia Li, Ka Ka Ting, Jinbiao Chen, Paul Coleman, Ken Liu, Li Wan, Thorleif Møller, Mathew A. Vadas, Jennifer R. Gamble	2020	23
5	Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models Diabetologia ·Ka Ka Ting, Yang Zhao, Weiyong Shen, Paul Coleman, Michelle Yam, Tailoi Chan‐Ling, Jia Li, Thorleif Møller, Mark C. Gillies, Mathew A. Vadas, Jennifer R. Gamble	2018	30
6	Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy Cancer Research ·Yang Zhao, Ka Ka Ting, Jia Li, Victoria C. Cogger, Jinbiao Chen, Anna Johansson, Shin Foong Ngiow, Jeff Holst, Georges E. Grau, Shom Goel, Polomoff, Elisabetta Dejana, Geoffrey W. McCaughan, Mark J. Smyth, Ruth Ganß, Mathew A. Vadas, Jennifer R. Gamble	2017	50
7	Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Jinbiao Chen, Wei Wang, Yanfei Qi, Dominik C. Kaczorowski, Geoffrey W. McCaughan, Jennifer R. Gamble, Anthony S. Don, Xin Gao, Mathew A. Vadas, Pu Xia	2015	44
8	Active subnetwork recovery with a mechanism-dependent scoring function; with application to angiogenesis and organogenesis studies BMC Bioinformatics ·Takumi Horita, Michael Charleston, Tibério S. Caetano, Jennifer R. Gamble, Mathew A. Vadas	2013	5
9	The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1 The International Journal of Biochemistry & Cell Biology ·Julia R. Zebol, Lars Garby, Paul A.B. Moretti, A. Dinter, B. Colombani, Peng Li, Mathew A. Vadas, Binks W. Wattenberg, Stuart M. Pitson	2008	15
10	Cryptomics : Identification of Novel Bioactive Peptides from Intact Proteins 千裕内藤, Youzou Miyadera, Soraya Coelho Costa Barroso, Tita Awah Margaret, Ying-pin Weng, Mathew A. Vadas	2007	1
11	Sphingosine kinase 1 is a critical component of the copper-dependent FGF1 export pathway Experimental Cell Research ·Raffaella Soldi, Anna Mandinova, Krishnan Venkataraman, Timothy Hla, Mathew A. Vadas, Stuart M. Pitson, Maria F. Duarte, Irene Graziani, Vihren N. Kolev, Doreen Kacer, Aleksandr Kirov, Thomas Maciag, Igor Prudovsky	2007	24
12	The Calmodulin-binding Site of Sphingosine Kinase and Its Role in Agonist-dependent Translocation of Sphingosine Kinase 1 to the Plasma Membrane Journal of Biological Chemistry ·María Elisa Casanova Domènech, Paul A.B. Moretti, Lars Garby, Christopher J. Bagley, Mathew A. Vadas, Stuart M. Pitson	2006	64
13	Regulation of haematopoiesis by growth factors – emerging insights and therapies Expert Opinion on Biological Therapy ·Danièl Thomas, Mathew A. Vadas, Angel F. López	2004	17
14	The Nucleotide-binding Site of Human Sphingosine Kinase 1 Journal of Biological Chemistry ·Stuart M. Pitson, Paul A.B. Moretti, Julia R. Zebol, Reza Zareie, Claudia K. Derian, Andrew L. Darrow, Jenson Qi, Richard J. D’Andrea, Christopher J. Bagley, Mathew A. Vadas, Binks W. Wattenberg	2002	90
15	Reconstitution of T Cell-Specific Transcription Directed by Composite NFAT/Oct Elements The Journal of Immunology ·Andrew G. Bert, Joanna Burrows, Abbas Hawwari, Mathew A. Vadas, Peter N. Cockerill	2000	34
16	An oncogenic role of sphingosine kinase Current Biology ·Pu Xia, Jennifer R. Gamble, Lijun Wang, Stuart M. Pitson, Paul A.B. Moretti, Binks W. Wattenberg, Richard J. D’Andrea, Mathew A. Vadas	2000	347
17	Hypoxic Regulation of Vascular Endothelial Growth Factor mRNA Stability Requires the Cooperation of Multiple RNA Elements Molecular Biology of the Cell ·Marlene Nelson, Diane Miller, Annette Damert, Werner Risau, Mathew A. Vadas, Gregory J. Goodall	1999	150
18	The vascular endothelial growth factor mRNA contains an internal ribosome entry site FEBS Letters ·Diane Miller, Marlene Nelson, Annette Damert, Werner Risau, Mathew A. Vadas, Gregory J. Goodall	1998	72
19	A T Cell–Specific Enhancer in the Interleukin-3 Locus Is Activated Cooperatively by Oct and NFAT Elements within a DNase I–Hypersensitive Site Immunity ·Barbara Sheen, Andrew G. Bert, Mathew A. Vadas, Peter N. Cockerill	1997	71
20	Human Granulocyte-Macrophage Colony-Stimulating Factor Enhancer Function Is Associated with Cooperative Interactions between AP-1 and NFATp/c Molecular and Cellular Biology ·Peter N. Cockerill, Andrew G. Bert, Harrell C. Dodson, Gregory R. Ryan, M Shannon, Mathew A. Vadas	1995	119

About Mathew A. Vadas

Mathew A. Vadas is a scholar working on Immunology and Allergy, Immunology, Parasitology, Cancer Research and Hematology, having authored 207 papers that have together received 17.4k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (45 papers), Sphingolipid Metabolism and Signaling (33 papers), Immune Response and Inflammation (33 papers), Immune Cell Function and Interaction (22 papers), Angiogenesis and VEGF in Cancer (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Parasites and Host Interactions (16 papers) and Platelet Disorders and Treatments (14 papers). The work is most often cited by research in Immunology and Allergy (1.9k citations), Cancer Research (3.7k citations), Immunology (4.4k citations), Molecular Biology (9.2k citations) and Cell Biology (2.2k citations). Mathew A. Vadas has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Jennifer R. Gamble, Yeesim Khew‐Goodall, Gregory J. Goodall, Andrew G. Bert, Simon C. Barry, Pu Xia, Anna Tsykin, Philip A. Gregory, Emily Paterson and Gelareh Farshid. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact